Delivery Order SPE2DB24D2100-SPE2DB25FBFSR
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,142.07 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $5,434.06. The contract employs firm fixed-price pricing and is classified as a non-set-aside competitive award. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order operates under...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $1,432.05 to provide NALOXONE 0.4 MG/ML vials. The contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is providing these pharmaceutical products to support military treatment programs and facilities. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,550.56 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 18, 2025. The contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,301.63 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray (2-pack units) on July 23, 2025, with completion required by July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,107.23 for Naloxone 1ML in quantities of 10 units by the Medical Supply Chain, a division within the Department of Defense. The contract employs firm fixed pricing with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is July 30, 2025, with performance to be conducted at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,470.53 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 4564091534 - NALOXONE .4MG/10ML 10S, a critical pharmaceutical product, through March 27, 2024. The contract has a ceiling value of $1,211.14 and does not have a set-aside designation. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $10,222.79. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of July 30, 2025, supporting federal medical procurement needs. The contract is classified as a child order under a larger indefinite delivery contract vehicle and carries no set-aside designation, indicating open...